NCT04807660 Bacteriological Evaluation of Children With Otorrhea
| NCT ID | NCT04807660 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Association Clinique Thérapeutique Infantile du val de Marne |
| Condition | Otorrhea |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2015-10-01 |
| Primary Completion | 2028-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2015-10-01 with a primary completion date of 2028-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
After pneumococcal conjugate vaccine implementation, the number of acute otitis media (AOM) episodes has decreased, but AOM still remains among the most common diagnoses in childhood. From 2% to 17% of cases of AOM feature spontaneous perforation of the tympanic membrane (SPTM). The aim of this study was to describe the bacteriological causes of SPTM several years after PCV13 implementation, in 2010.
Eligibility Criteria
Inclusion Criteria: * children from 3 months to 15 years old * with otorrhea * signed parents consent Exclusion Criteria: * children under 3 months * children \> 15 years old
Contact & Investigator
Robert Cohen
STUDY DIRECTOR
Association Clinique et Thérapeutique Infantile du Val de Marne
Frequently Asked Questions
Who can join the NCT04807660 clinical trial?
This trial is open to participants of all sexes, aged 3 Months or older, up to 15 Years, studying Otorrhea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04807660 currently recruiting?
Yes, NCT04807660 is actively recruiting participants. Contact the research team at corinne.levy@activ-france.fr for enrollment information.
Where is the NCT04807660 trial being conducted?
This trial is being conducted at Créteil, France.
Who is sponsoring the NCT04807660 clinical trial?
NCT04807660 is sponsored by Association Clinique Thérapeutique Infantile du val de Marne. The principal investigator is Robert Cohen at Association Clinique et Thérapeutique Infantile du Val de Marne. The trial plans to enroll 1,500 participants.